Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Venkataramaiah Chintha & Rajendra Wudayagiri. (2019) Bioavailability and Neuroprotectivity of 3-(3, 4-dimethoxy phenyl)-1-4 (methoxy phenyl) prop-2-en-1-one against Schizophrenia: an in silico approach. Journal of Receptors and Signal Transduction 39:5-6, pages 392-398.
Read now
Read now
Gary Probst & Ying-zi Xu. (2012) Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011). Expert Opinion on Therapeutic Patents 22:5, pages 511-540.
Read now
Read now
Robert A Philibert & Howard K Gershenfeld. (2007) Therapeutic potential of targeting gene variants in schizophrenia. Expert Review of Neurotherapeutics 7:7, pages 757-760.
Read now
Read now
Edward M. Scolnick, Tracey Petryshen & Pamela Sklar. (2006) Schizophrenia: Do the Genetics and Neurobiology of Neuregulin Provide a Pathogenesis Model?. Harvard Review of Psychiatry 14:2, pages 64-77.
Read now
Read now
Marie-Odile Krebs. (2005) Future contributions on genetics. The World Journal of Biological Psychiatry 6:sup2, pages 49-55.
Read now
Read now
Articles from other publishers (89)
Aleksandra Góralczyk-Bińkowska, Dagmara Szmajda-Krygier & Elżbieta Kozłowska. (2022) The Microbiota–Gut–Brain Axis in Psychiatric Disorders. International Journal of Molecular Sciences 23:19, pages 11245.
Crossref
Crossref
Nan Su, Weiqi Zhang, Nicole Eter, Peter Heiduschka & Mingyue Zhang. (2022) Overexpression of Neuregulin-1 Type III Has Impact on Visual Function in Mice. International Journal of Molecular Sciences 23:9, pages 4489.
Crossref
Crossref
Raquel Garcia-Lopez, Ana Pombero, Alicia Estirado, Emilio Geijo-Barrientos & Salvador Martinez. (2021) Interneuron Heterotopia in the Lis1 Mutant Mouse Cortex Underlies a Structural and Functional Schizophrenia-Like Phenotype. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yacoubou Abdoul Razak Mahaman, Fang Huang, Kidane Siele Embaye, Xiaochuan Wang & Feiqi Zhu. (2021) The Implication of STEP in Synaptic Plasticity and Cognitive Impairments in Alzheimer’s Disease and Other Neurological Disorders. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Liang Shi & Clare M. Bergson. (2020) Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders. Translational Psychiatry 10:1.
Crossref
Crossref
Jessica M. Noll, Yonggang Li, Timothy J. Distel, Gregory D. Ford & Byron D. Ford. (2019) Neuroprotection by Exogenous and Endogenous Neuregulin-1 in Mouse Models of Focal Ischemic Stroke. Journal of Molecular Neuroscience 69:2, pages 333-342.
Crossref
Crossref
Hardeep Kataria, Arsalan Alizadeh & Soheila Karimi-Abdolrezaee. (2019) Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair. Progress in Neurobiology 180, pages 101643.
Crossref
Crossref
Tuba ÖZKUL & Asuman GÖLGELİ. (2019) Deneysel şizofreni modellerinin oluşturulması ve deneysel yöntemlerle şizofreni belirtilerinin değerlendirilmesiDevelopment of experimental schizophrenia models and evaluation of schizophrenia symptoms with tests. Mersin Üniversitesi Sağlık Bilimleri Dergisi 12:2, pages 351-359.
Crossref
Crossref
Liangying Yin, Eric Fuk-Chi Cheung, Ronald Yuk-Lun Chen, Emily Hoi-Man Wong, Pak-Chung Sham & Hon-Cheong So. (2018) Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups. Journal of Psychiatric Research 106, pages 106-117.
Crossref
Crossref
Erman Esnafoglu. (2018) Levels of peripheral Neuregulin 1 are increased in non-medicated autism spectrum disorder patients. Journal of Clinical Neuroscience 57, pages 43-45.
Crossref
Crossref
Megan M. Wickens, Debra A. Bangasser & Lisa A. Briand. (2018) Sex Differences in Psychiatric Disease: A Focus on the Glutamate System. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Ting‑Ting Zhang, Ning Qu, Guo‑Hua Sun, Long Zhang, Yuan‑Jin Wang, Xiang‑Ming Mu, Wen‑Jun Wei, Yu‑Long Wang, Yu Wang, Qing‑Hai Ji, Yong‑Xue Zhu & Rong‑Liang Shi. (2018) NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer. International Journal of Oncology.
Crossref
Crossref
Y.N. Dong, H. Lin, A. Rattelle, J. Panzer & D.R. Lynch. 2018. Comprehensive Toxicology. Comprehensive Toxicology
70
100
.
Mariliis Vaht, Kariina Laas, Evelyn Kiive, Jüri Parik, Toomas Veidebaum & Jaanus Harro. (2016) A functional neuregulin-1 gene variant and stressful life events: Effect on drug use in a longitudinal population-representative cohort study. Journal of Psychopharmacology 31:1, pages 54-61.
Crossref
Crossref
Tatiana Ammosova, Kareem Washington, Jamie Rotimi, Namita Kumari, Kahli Smith, Xiaomei Niu, Marina Jerebtsova & Sergei Nekhai. (2016) Protein Phosphatase-1 Regulates Expression of Neuregulin-1. Biology 5:4, pages 49.
Crossref
Crossref
Claudia S. Barz, Thomas Bessaih, Ted Abel, Dirk Feldmeyer & Diego Contreras. (2015) Altered resonance properties of somatosensory responses in mice deficient for the schizophrenia risk gene Neuregulin 1. Brain Structure and Function 221:9, pages 4383-4398.
Crossref
Crossref
Tijana Copf. (2016) Impairments in dendrite morphogenesis as etiology for neurodevelopmental disorders and implications for therapeutic treatments. Neuroscience & Biobehavioral Reviews 68, pages 946-978.
Crossref
Crossref
Michael Willem. (2016) Proteolytic processing of Neuregulin-1. Brain Research Bulletin 126, pages 178-182.
Crossref
Crossref
Cunyan Li, Yamei Tang, Jingjing Yang, Xianghui Zhang, Yong Liu & Aiguo Tang. (2016) Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model. Neurochemical Research 41:8, pages 2049-2064.
Crossref
Crossref
A E Hoban, R M Stilling, F J Ryan, F Shanahan, T G Dinan, M J Claesson, G Clarke & J F Cryan. (2016) Regulation of prefrontal cortex myelination by the microbiota. Translational Psychiatry 6:4, pages e774-e774.
Crossref
Crossref
D-M Yin, Y-J Chen, S Liu, H Jiao, C Shen, A Sathyamurthy, T W Lin, W-C Xiong, B-M Li, L Mei & C Bergson. (2014) Calcyon stimulates neuregulin 1 maturation and signaling. Molecular Psychiatry 20:10, pages 1251-1260.
Crossref
Crossref
Martin J Schmidt & Karoly Mirnics. (2014) Neurodevelopment, GABA System Dysfunction, and Schizophrenia. Neuropsychopharmacology 40:1, pages 190-206.
Crossref
Crossref
Tadasato Nagano, Makoto Mizuno, Keisuke Morita & Hiroyuki Nawa. 2016. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology
429
446
.
Sherry Leonard. 2014. Nicotinic Receptors. Nicotinic Receptors
417
434
.
Mark Walker. 2013. Happy‐People‐Pills For All. Happy‐People‐Pills For All
155
186
.
Ketan Marballi, Dianne Cruz, Peter Thompson & Consuelo Walss-Bass. (2012) Differential Neuregulin 1 Cleavage in the Prefrontal Cortex and Hippocampus in Schizophrenia and Bipolar Disorder: Preliminary Findings. PLoS ONE 7:5, pages e36431.
Crossref
Crossref
Teresa Marie du Bois, Kelly Anne Newell & Xu-Feng Huang. (2012) Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life. European Neuropsychopharmacology 22:5, pages 356-363.
Crossref
Crossref
Sarah Tosato, Marcella Bellani, Chiara Bonetto, Mirella Ruggeri, Cinzia Perlini, Antonio Lasalvia, Veronica Marinelli, Gianluca Rambaldelli, Doriana Cristofalo, Mariaelena Bertani, Martina Zanoni, Lorenza Lazzarotto, Roberto Cerini, Roberto Pozzi Mucelli, Michele Tansella, Paola Dazzan, Marta Di Forti, Robin M. Murray, David A. Collier & Paolo Brambilla. (2012) Is Neuregulin 1 Involved in Determining Cerebral Volumes in Schizophrenia Preliminary Results Showing a Decrease in Superior Temporal Gyrus Volume. Neuropsychobiology 65:3, pages 119-125.
Crossref
Crossref
Masaya Yanagi, Sarah Southcott, Jacob Lister & Carol A. Tamminga. 2012. Animal Models of Molecular Pathology. Animal Models of Molecular Pathology
411
444
.
Claire MeissirelCarmen Ruiz de AlmodovarEllen KnevelsCathy CoulonNaura ChounlamountriInmaculada SeguraPierre de RossiStefan VinckierKristof AnthonisBérangère DelégliseMaria de MolCarine AliKarel DassonvilleEllen LoyensJérôme HonnoratYvette MichotteVéronique RogemondIlse SmoldersThomas Voets, Denis VivienPieter Vanden BergheLudo Van Den BoschWim RobberechtAlain ChédotalSalvatore Oliviero, Mieke DewerchinDietmar SchmuckerNicole ThomassetPaul Salin & Peter Carmeliet. (2011) VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proceedings of the National Academy of Sciences 108:33, pages 13782-13787.
Crossref
Crossref
Chang-Gyu Hahn. (2011) A Src link in schizophrenia. Nature Medicine 17:4, pages 425-427.
Crossref
Crossref
M. Shaikh, M.-H. Hall, K. Schulze, A. Dutt, M. Walshe, I. Williams, M. Constante, M. Picchioni, T. Toulopoulou, D. Collier, F. Rijsdijk, J. Powell, M. Arranz, R. M. Murray & E. Bramon. (2010)
Do
COMT
,
BDNF
and
NRG1
polymorphisms influence P50 sensory gating in psychosis?
. Psychological Medicine 41:2, pages 263-276.
Crossref
Crossref
Lingling Lu, Takayoshi Mamiya, Takenao Koseki, Akihiro Mouri & Toshitaka Nabeshima. (2011) Genetic Animal Models of Schizophrenia Related with the Hypothesis of Abnormal Neurodevelopment. Biological & Pharmaceutical Bulletin 34:9, pages 1358-1363.
Crossref
Crossref
Adel Barakat, Brian Dean, Elizabeth Scarr & Geneviève Evin. (2010) Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophrenia Research 124:1-3, pages 200-207.
Crossref
Crossref
Anamika Banerjee, Mathew L. MacDonald, Karin E. Borgmann-Winter & Chang-Gyu Hahn. (2010) Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome. Brain Research Bulletin 83:3-4, pages 132-139.
Crossref
Crossref
Christina Wilson & Alvin TerryJr.Jr.. (2010) Neurodevelopmental Animal Models of Schizophrenia: Role in Novel Drug Discovery and Development. Clinical Schizophrenia & Related Psychoses 4:2, pages 124-137.
Crossref
Crossref
A. Schmechtig, E. Vassos, V. Kumari, S. B. Hutton, D. A. Collier, R. G. Morris, S. C. R. Williams & U. Ettinger. (2010) Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements. Genes, Brain and Behavior, pages no-no.
Crossref
Crossref
Maile A. Henson, Adam C. Roberts, Isabel Pérez-Otaño & Benjamin D. Philpot. (2010) Influence of the NR3A subunit on NMDA receptor functions. Progress in Neurobiology 91:1, pages 23-37.
Crossref
Crossref
Andrea Schmitt, Jiri Koschel, Mathias Zink, Manfred Bauer, Clemens Sommer, Josef Frank, Jens Treutlein, Thomas Schulze, Thomas Schneider-Axmann, Eleni Parlapani, Marcella Rietschel, Peter Falkai & Fritz A. Henn. (2009) Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 260:2, pages 101-111.
Crossref
Crossref
Makoto Mizuno, Yuriko Iwakura, Masako Shibuya, Yingjun Zheng, Takeyoshi Eda, Taisuke Kato, Yohei Takasu & Hiroyuki Nawa. (2010) Antipsychotic Potential of Quinazoline ErbB1 Inhibitors in a Schizophrenia Model Established With Neonatal Hippocampal Lesioning. Journal of Pharmacological Sciences 114:3, pages 320-331.
Crossref
Crossref
Deepak Cyril D’Souza, Richard Andrew Sewell & Mohini Ranganathan. (2009) Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience 259:7, pages 413-431.
Crossref
Crossref
Michael Willem, Sven Lammich & Christian Haass. (2009) Function, regulation and therapeutic properties of β-secretase (BACE1). Seminars in Cell & Developmental Biology 20:2, pages 175-182.
Crossref
Crossref
Tilo Kircher, Renate Thienel, Michael Wagner, Martina Reske, Ute Habel, Thilo Kellermann, Ingo Frommann, Sibylle Schwab, Wolfgang Wölwer, Martina von Wilmsdorf, Dieter F. Braus, Andrea Schmitt, Alexander Rapp, Tony Stöcker, N. Jon Shah, Fritz A. Henn, Heinrich Sauer, Wolfgang Gaebel, Wolfgang Maier & Frank Schneider. (2008) Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. European Archives of Psychiatry and Clinical Neuroscience 259:2, pages 72-79.
Crossref
Crossref
Steven J. Siegel, Mary E. Dankert & Jennifer M. Phillips. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
797
815
.
Michael S. Ritsner & Ehud Susser. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
95
124
.
K. Q. Do, P. Bovet, J. H. Cabungcal, P. Conus, R. Gysin, S. Lavoie, P. Steullet & M. Cuenod. 2009. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
285
311
.
Y.-J. J. Chen, L. W. Role & D. A. Talmage. 2009. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
243
265
.
Oliver Gruber, Peter Falkai, Thomas Schneider-Axmann, Sibylle G. Schwab, Michael Wagner & Wolfgang Maier. (2008) Neuregulin-1 haplotype HAPICE is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. Journal of Psychiatric Research 43:1, pages 1-6.
Crossref
Crossref
Graham Pitcher, Lorraine Kalia, Xue Jun Liu, Michael Salter & Yina Dong. 2008. Biology of the NMDA Receptor. Biology of the NMDA Receptor
123
148
.
Chongbo Zhong, Chuang Du, Melissa Hancock, Marjolijn Mertz, David A. Talmage & Lorna W. Role. (2008) Presynaptic Type III Neuregulin 1 Is Required for Sustained Enhancement of Hippocampal Transmission by Nicotine and for Axonal Targeting of α7 Nicotinic Acetylcholine Receptors. The Journal of Neuroscience 28:37, pages 9111-9116.
Crossref
Crossref
Lyudmila Georgieva, Albena Dimitrova, Dobril Ivanov, Ivan Nikolov, Nigel M. Williams, Detelina Grozeva, Irina Zaharieva, Draga Toncheva, Michael J. Owen, George Kirov & Michael C. O'Donovan. (2008) Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia. Biological Psychiatry 64:5, pages 419-427.
Crossref
Crossref
Mark J. Millan & Mauricette Brocco. (2008) Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138. Therapies 63:3, pages 187-229.
Crossref
Crossref
Stacey Williams, Colleen Ryan & Christian Jacobson. (2008) Agrin and neuregulin, expanding roles and implications for therapeutics. Biotechnology Advances 26:3, pages 187-201.
Crossref
Crossref
G Karoutzou, H M Emrich & D E Dietrich. (2007) The myelin-pathogenesis puzzle in schizophrenia: a literature review. Molecular Psychiatry 13:3, pages 245-260.
Crossref
Crossref
Elisabet Vilella, Javier Costas, Julio Sanjuan, Míriam Guitart, Yolanda De Diego, Angel Carracedo, Lourdes Martorell, Joaquín Valero, Antonio Labad, Rosa De Frutos, Carmen Nájera, M. Dolores Moltó, Ivette Toirac, Roser Guillamat, Anna Brunet, Vicenç Vallès, Lucía Pérez, Melquíades Leon, Fernando Rodríguez de Fonseca, Christopher Phillips & María Torres. (2008) Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. Journal of Psychiatric Research 42:4, pages 278-288.
Crossref
Crossref
Katherine H. Karlsgodt, Daqiang Sun, Amy M. Jimenez, Evan S. Lutkenhoff, Rachael Willhite, Theo G. M. van Erp & Tyrone D. Cannon. (2008) Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Development and Psychopathology 20:4, pages 1297-1327.
Crossref
Crossref
T. Karl, L. Duffy, A. Scimone, R. P. Harvey & P. R. Schofield. (2007) Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes, Brain and Behavior 6:7, pages 677-687.
Crossref
Crossref
Dorit Ben-Shachar & Rachel Karry. (2007) Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2. PLoS ONE 2:9, pages e817.
Crossref
Crossref
A Bellon. (2007) New genes associated with schizophrenia in neurite formation: a review of cell culture experiments. Molecular Psychiatry 12:7, pages 620-629.
Crossref
Crossref
Stephan Züchner, Sushma T Roberts, Marcy C Speer & Jean C Beckham. (2007) Update on psychiatric genetics. Genetics in Medicine 9:6, pages 332-340.
Crossref
Crossref
Liam Carroll, Michael C. O'Donovan & Michael J. Owen. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Mia Thompson, Simone Lauderdale, Maree J. Webster, Victor Z. Chong, Benjamin McClintock, Richard Saunders & Cynthia Shannon Weickert. (2007) Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Research 1139, pages 95-109.
Crossref
Crossref
H. Knoblauch. (2007) Schizophrenie, Humangenetik und genetische BeratungSchizophrenia, human genetics and genetic counselling. Der Nervenarzt 78:3, pages 243-252.
Crossref
Crossref
Teresa Marie du Bois & Xu-Feng Huang. (2007) Early brain development disruption from NMDA receptor hypofunction: Relevance to schizophrenia. Brain Research Reviews 53:2, pages 260-270.
Crossref
Crossref
Colin A Hodgkinson, David Goldman, Francesca Ducci, Pamela DeRosse, Daniel A Caycedo, Emily R Newman, John M Kane, Alec Roy & Anil K Malhotra. (2006) The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations. Neuropsychopharmacology 32:1, pages 190-196.
Crossref
Crossref
Colm M.P. O’Tuathaigh, Daniela Babovic, Gillian O’Meara, Jeremiah J. Clifford, David T. Croke & John L. Waddington. (2007) Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour. Neuroscience & Biobehavioral Reviews 31:1, pages 60-78.
Crossref
Crossref
J E Severinsen, C R Bjarkam, S Kiar-Larsen, I M Olsen, M M Nielsen, J Blechingberg, A L Nielsen, I E Holm, L Foldager, B D Young, W J Muir, D H R Blackwood, T J Corydon, O Mors & A D Borglum. (2006) Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Molecular Psychiatry 11:12, pages 1126-1138.
Crossref
Crossref
Annie Andrieux, Paul Salin, Annie Schweitzer, Mélina Bégou, Bastien Pachoud, Philippe Brun, Sylvie Gory-Fauré, Pekka Kujala, Marie-Françoise Suaud-Chagny, Gerhard Höfle & Didier Job. (2006) Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia. Biological Psychiatry 60:11, pages 1224-1230.
Crossref
Crossref
Ann Van Den Bogaert, Jurgen Del-Favero & Christine Van Broeckhoven. (2006) Major affective disorders and schizophrenia: a common molecular signature?. Human Mutation 27:9, pages 833-853.
Crossref
Crossref
Chang-Gyu Hahn, Hoau-Yan Wang, Dan-Sung Cho, Konrad Talbot, Raquel E Gur, Wade H Berrettini, Kalindi Bakshi, Joshua Kamins, Karin E Borgmann-Winter, Steven J Siegel, Robert J Gallop & Steven E Arnold. (2006) Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia. Nature Medicine 12:7, pages 824-828.
Crossref
Crossref
Dawei Li, David A. Collier & Lin He. (2006) Meta-analysis shows strong positive association of the neuregulin 1 (
NRG1
) gene with schizophrenia. Human Molecular Genetics 15:12, pages 1995-2002.
Crossref
Crossref
Jingshan Chen, Barbara K. Lipska & Daniel R. Weinberger. (2006) Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models. Biological Psychiatry 59:12, pages 1180-1188.
Crossref
Crossref
Hans-Gert Bernstein, Uwe Lendeckel, Iris Bertram, Alicja Bukowska, Dimitrios Kanakis, Henrik Dobrowolny, Renate Stauch, Dieter Krell, Christian Mawrin, Eike Budinger, Gerburg Keilhoff & Bernhard Bogerts. (2006) Localization of neuregulin-1α (heregulin-α) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain. Brain Research Bulletin 69:5, pages 546-559.
Crossref
Crossref
Jong Won Kim, Yu‐Sang Lee, Eun‐Young Cho, Yong Lee Jang, Dong Yeon Park, Kyeong‐Sook Choi, Hyun Ok Jeun, Seung‐Hee Cho, Sue‐Yon Jang & Kyung Sue Hong. (2006) Linkage and association of schizophrenia with genetic variations in the locus of neuregulin 1 in Korean population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B:3, pages 281-286.
Crossref
Crossref
Neil A. Holtzman. (2006) What Role for Public Health in Genetics and Vice Versa?. Public Health Genomics 9:1, pages 8-20.
Crossref
Crossref
Alasdair M. Barr, Clint E. Young, Ken Sawada & William G. Honer. 2006. Molecular Mechanisms of Synaptogenesis. Molecular Mechanisms of Synaptogenesis
391
408
.
Howard K. Gershenfeld, Robert A. Philibert & Gary W. Boehm. (2005) Looking Forward in Geriatric Anxiety and Depression: Implications of Basic Science for the Future. The American Journal of Geriatric Psychiatry 13:12, pages 1027-1040.
Crossref
Crossref
Oh-Bin Kwon, Marines Longart, Detlef Vullhorst, Dax A. Hoffman & Andres Buonanno. (2005) Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses. The Journal of Neuroscience 25:41, pages 9378-9383.
Crossref
Crossref
Jehannine Austin. (2005) Schizophrenia: An Update and Review. Journal of Genetic Counseling 14:5, pages 329-340.
Crossref
Crossref
M.J. Owen, N. Craddock & M.C. O'Donovan. (2005) Schizophrenia: genes at last?. Trends in Genetics 21:9, pages 518-525.
Crossref
Crossref
Lambertus Klei, Silviu-Alin Bacanu, Marina Myles-Worsley, Brandi Galke, Weiting Xie, Josepha Tiobech, Caleb Otto, Kathyrn Roeder, Bernie Devlin & William Byerley. (2005) Linkage analysis of a completely ascertained sample of familial schizophrenics and bipolars from Palau, Micronesia. Human Genetics 117:4, pages 349-356.
Crossref
Crossref
Philippe Brun, Melina Begou, Annie Andrieux, Laurence Mouly-Badina, Magali Clerget, Annie Schweitzer, Helene Scarna, Bernard Renaud, Didier Job & Marie-Francoise Suaud-Chagny. (2005) Dopaminergic transmission in STOP null mice. Journal of Neurochemistry 94:1, pages 63-73.
Crossref
Crossref
P A Thomson, N R Wray, J K Millar, K L Evans, S Le Hellard, A Condie, W J Muir, D H R Blackwood & D J Porteous. (2005) Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Molecular Psychiatry 10:7, pages 657-668.
Crossref
Crossref
Mark J. Millan. (2005) N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179:1, pages 30-53.
Crossref
Crossref
William Y. S. Wang, Bryan J. Barratt, David G. Clayton & John A. Todd. (2005) Genome-wide association studies: theoretical and practical concerns. Nature Reviews Genetics 6:2, pages 109-118.
Crossref
Crossref
P J Harrison & D R Weinberger. (2004) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10:1, pages 40-68.
Crossref
Crossref
Steven E. Arnold, Konrad Talbot & Chang-Gyu Hahn. 2005. Development, Dynamics and Pathiology of Neuronal Networks: from Molecules to Functional Circuits. Development, Dynamics and Pathiology of Neuronal Networks: from Molecules to Functional Circuits
319
345
.
Olli Kampman, Sami Anttila, Ari Illi, Marika Saarela, Riikka Rontu, Kari M. Mattila, Esa Leinonen & Terho Lehtimäki. (2004) Neuregulin genotype and medication response in Finnish patients with schizophrenia. NeuroReport 15:16, pages 2517-2520.
Crossref
Crossref
Joseph T. Coyle. (2004) The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochemical Pharmacology 68:8, pages 1507-1514.
Crossref
Crossref